2026 Provider Letters
| Letter Number | Subject | Date Added to Website |
|---|---|---|
| 2026-09 | RE: Prior Authorization Nyvepria™ - Effective June 15, 2026 | 5/7/26 |
| 2026-08 | RE: Telehealth Originating Site Facility Fee | 5/1/26 |
| 2026-07 | RE: Office/Outpatient Monthly Visit Limits | 5/1/26 |
| 2026-06 | RE: Prior Authorization or Certain Intravenous and Subcutaneous Immunoglobulins Effective May 1, 2026 | 4/7/26 |
| 2026-05 | RE: Product-Based Prior Authorization for Hereditary Angioedema Medications Effective May 1, 2026 | 4/2/26 |
| 2026-04 | RE: D9248 update | 2/19/26 |
| 2026-03 | RE: Action Required: Amended Executive Order 2025-16 | 1/21/26 |
| 2026-02 | RE: Important Update to Provider Contracting and Credentialing | 1/8/26 |
| 2026-01 | RE: Yearly Compliance with the Deficit Reduction Act of 2005 – FFY 2025 | 1/6/26 |
Last Modified on
May 07, 2026
